Singapore set out on a journey to become a biotech hub back in 2000 when the local government made biomedical research the “fourth pillar” of the city state’s economy in what’s known as the National Biomedical Science Strategy. Under that initiative, Singapore in 2003 established Biopolis, a custom-built biomedical R&D hub.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in